NT219 |
Catalog No.GC69599 |
NT219 is an effective dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3. IRS1/2 and STAT3 are major signaling pathways regulated by various oncogenes. NT219 affects the degradation of IRS1/2 and inhibits the phosphorylation of STAT3. NT219 has potential for researching cancer diseases.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1198078-60-2
Sample solution is provided at 25 µL, 10mM.
Review for NT219
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for NT219
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *